SYMBIOTEC PHARMALABShare price target & analyst calls
₹1,198+21.25 (+1.81%)
Only one active 1-year target
The long-term call is BUY₹1,54028.5% above today's price
SYMBIOTEC PHARMALAB has one active 1-year share price target: ₹1,540 from ICICI Securities (1 Oct 2026). One target is a single view, not a consensus.
1
1 BUY · 0 SELL, all horizons
1
with an active 1Y target
N/A
0 of 10 closed calls needed
1
all horizons, open and closed
Watch SYMBIOTEC for new buy/sell callsGet alertsSee 59 Pharmaceuticals & Biotechnology sector analyst picks
Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.
All tips (1)
ISbyICICI Securities+28.5% to target
1 Year* · 12 mo left · 1 Oct 2026 · entry ₹1,198 · via Institutional / Brokerage ResearchP&L 0.0%
* Horizon not stated by the source; assumed from how far the target is from the entry price.
Compare Pharmaceuticals & Biotechnology targets
Most-covered stocks in the sector · average 1-year target
- CIPLACipla Ltd.₹1,501+11.7% · 16 calls
- DRREDDYDr. Reddy's Laboratories Limited₹1,342+11.2% · 16 calls
- SUNPHARMASun Pharmaceutical Industries Ltd.₹2,227+23.7% · 15 calls
- BIOCONBiocon Ltd₹485+30.9% · 12 calls
- LUPINLupin Limited₹2,576+26.8% · 12 calls
- SYMBIOTEC· this stockSYMBIOTEC PHARMALAB LTD₹1,540+28.5% · 1 call